Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Labcorp Holdings (LH)
NYSE:LH
LH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$191.97 - $258.59
Previous CloseN/A
Volume103.18K
Average Volume (3M)606.17K
Market Cap
$20.84B
Enterprise Value$25.07B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)28.2
Beta0.56
Next Earnings
Apr 24, 2025EPS Estimate
3.81Next Dividend Ex-Date
Feb 27, 2025Dividend Yield1.16%
Share Statistics
EPS (TTM)8.83
Shares Outstanding83,639,260
10 Day Avg. Volume601,534
30 Day Avg. Volume606,174
Standard Deviation0.09
R-Squared0.41
Alpha-0.00235
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.63
Price to Cash Flow (P/CF)18.70
P/FCF Ratio26.10
Enterprise Value/Market Cap1.20
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.45
Enterprise Value/Ebitda17.72
Forecast
1Y Price Target
$277.08Price Target Upside11.20% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
---
Bulls Say, Bears Say
Bulls Say
Financial HealthLabcorp Holdings has significant cash reserves and authorized share repurchase, indicating strong financial health and strategic flexibility.
Financial PerformanceLabcorp Holdings posted solid fourth-quarter results, surpassing expectations with sales of $3.33 billion and adjusted EPS of $3.45.
GuidanceThe company initiated a full-year 2025 sales guide at the midpoint ahead of expectations, indicating strong future growth.
Bears Say
BacklogBacklog decreased ~3.2% due to foreign exchange.
EPS GuidanceUpdated 2024 adjusted EPS was reduced $0.10 at the midpoint, reflecting the negative impact from weather.
MarginsMargins were light on transient items despite solid sales and EPS performance.
---
Ownership Overview
0.32% Insiders
27.76% Mutual Funds
23.11% Other Institutional Investors
25.32% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LH FAQ
What was Labcorp Holdings’s price range in the past 12 months?
Labcorp Holdings lowest stock price was $191.97 and its highest was $258.59 in the past 12 months.
What is Labcorp Holdings’s market cap?
Labcorp Holdings’s market cap is $20.84B.
When is Labcorp Holdings’s upcoming earnings report date?
Labcorp Holdings’s upcoming earnings report date is Apr 24, 2025 which is in 61 days.
How were Labcorp Holdings’s earnings last quarter?
Labcorp Holdings released its earnings results on Feb 06, 2025. The company reported $3.45 earnings per share for the quarter, beating the consensus estimate of $3.392 by $0.058.
Is Labcorp Holdings overvalued?
According to Wall Street analysts Labcorp Holdings’s price is currently Undervalued.
Does Labcorp Holdings pay dividends?
Labcorp Holdings pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 1.16%. See more information on Labcorp Holdings dividends here
What is Labcorp Holdings’s EPS estimate?
Labcorp Holdings’s EPS estimate is 3.81.
How many shares outstanding does Labcorp Holdings have?
Labcorp Holdings has 83,639,260 shares outstanding.
What happened to Labcorp Holdings’s price movement after its last earnings report?
Labcorp Holdings reported an EPS of $3.45 in its last earnings report, beating expectations of $3.392. Following the earnings report the stock price went down -0.9%.
Which hedge fund is a major shareholder of Labcorp Holdings?
Currently, no hedge funds are holding shares in LH
---
Labcorp Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$277.08 (11.20% Upside)
$277.08 (11.20% Upside)
Blogger Sentiment
Neutral
LH Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 6.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days >0.1%
Last 30 Days ▲ 5.9%
Last 30 Days ▲ 5.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.05%
12-Months-Change
Fundamentals
Return on Equity
9.37%
Trailing 12-Months
Asset Growth
9.89%
Trailing 12-Months
Company Description
Labcorp Holdings
Laboratory Corp. of America Holdings is a clinical laboratory company, which engages in the provision of clinical laboratory and end-to-end drug development services. It operates through the LabCorp Diagnostics and Covance Drug Development segments. The LabCorp Diagnostics segment includes core testing as well as genomic and esoteric testing. The Covance Drug Development segment involves in providing drug development solutions, to companies in the pharmaceutical and biotechnology industries. The company was founded in 1971 and is headquartered in Burlington, NC.
---
LH Company Deck
---
LH Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment with strong revenue growth across diagnostics and biopharma segments, successful acquisitions, and promising guidance for 2025. However, there are concerns about margin decline due to acquisitions and higher personnel costs.Read More>---
LH Revenue Breakdown
77.42% Dx
22.81% BLS
---
LH Stock 12 Month Forecast
Average Price Target
$277.08
▲(11.20% Upside)
Technical Analysis
Best Analysts Covering LH
1 Year
1 Year Success Rate
20/22 ratings generated profit
1 Year Average Return
+15.53%
reiterated a buy rating 2 months ago
Copying Erin Wright's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +15.53% per trade.
---